Diagnosis and Management of Cyclodextrin-Responsive Syringomyelia: Implications for Pharmacy, Nursing, and General Medicine
DOI:
https://doi.org/10.22399/ijcesen.4538Keywords:
Syringomyelia, Cyclodextrin, 2-hydroxypropyl-β-cyclodextrin (HPβCD), Diagnosis, ManagementAbstract
Cyclodextrin-responsive syringomyelia represents a novel syndrome characterized by the presence of a syrinx (cyst inside the spinal cord) that responds to treatment with cyclodextrins, specifically 2-hydroxypropyl-β-cyclodextrin (HPβCD). Accurate diagnosis is crucial and often involves a combination of clinical assessment, imaging studies such as MRI, and a detailed patient history. Symptoms may include pain, weakness, and sensory disturbances, which require a comprehensive evaluation by healthcare practitioners. Early detection and intervention can help prevent irreversible neurological damage. For pharmacists, understanding the pharmacokinetics and potential side effects of cyclodextrins is essential for ensuring patient safety and optimizing therapeutic outcomes. The management of cyclodextrin-responsive syringomyelia necessitates a multidisciplinary approach involving physicians, pharmacists, and nursing staff. Pharmacists play a vital role in medication management, including monitoring for potential drug interactions and counseling patients about the use of cyclodextrin therapies. Nurses are frequently on the frontline, providing education, emotional support, and navigation through the healthcare system while assessing treatment efficacy and patient adherence to prescribed regimens. This collaborative effort extends to general medicine, where the integration of knowledge about cyclodextrin-responsive conditions into everyday practice can improve patient outcomes. Continuing education and research are paramount in elucidating the best practices for managing this emerging condition.
References
1. Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C, Speer MC. Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery. 1999 May;44(5):1005-17. DOI: https://doi.org/10.1097/00006123-199905000-00042
2. Grant R, Hadley DM, Macpherson P, Condon B, Patterson J, Bone I, Teasdale GN. Syringomyelia: cyst measurement by magnetic resonance imaging and comparison with symptoms, signs and disability. J Neurol Neurosurg Psychiatry. 1987 Aug;50(8):1008-14. DOI: https://doi.org/10.1136/jnnp.50.8.1008
3. Greitz D. Unraveling the riddle of syringomyelia. Neurosurg Rev. 2006 Oct;29(4):251-63; discussion 264. DOI: https://doi.org/10.1007/s10143-006-0029-5
4. Wang S, Zhang D, Wu K, Fan W, Fan T. Potential association among posterior fossa bony volume and crowdedness, tonsillar hernia, syringomyelia, and CSF dynamics at the craniocervical junction in Chiari malformation type I. Front Neurol. 2023;14:1069861. DOI: https://doi.org/10.3389/fneur.2023.1069861
5. Koyanagi I, Houkin K. Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis. Neurosurg Rev. 2010 Jul;33(3):271-84; discussion 284-5. DOI: https://doi.org/10.1007/s10143-010-0266-5
6. Shao B, Wojcik D, Ma KL, Amaral-Nieves N, Poggi JA, Leary OP, Klinge PM. Reappraisal of intradural findings in Chiari malformation type I. Neurosurg Focus. 2023 Mar;54(3):E2. DOI: https://doi.org/10.3171/2022.12.FOCUS22628
7. Ball MJ, Dayan AD. Pathogenesis of syringomyelia. Lancet. 1972 Oct 14;2(7781):799-801. DOI: https://doi.org/10.1016/S0140-6736(72)92152-6
8. Williams B. Post-traumatic syringomyelia, an update. Paraplegia. 1990 Jun;28(5):296-313. DOI: https://doi.org/10.1038/sc.1990.39
9. Ciaramitaro P, Garbossa D, Peretta P, Piatelli G, Massimi L, Valentini L, Migliaretti G, Baldovino S, Roccatello D, Kodra Y, Taruscio D., Interregional Chiari and Syringomyelia Consortium. on behalf of the Interregional Chiari and Syringomyelia Consortium. Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North Western Italy cohort. Ann Ist Super Sanita. 2020 Jan-Mar;56(1):48-58.
10. Klekamp J, Batzdorf U, Samii M, Bothe HW. Treatment of syringomyelia associated with arachnoid scarring caused by arachnoiditis or trauma. J Neurosurg. 1997 Feb;86(2):233-40. DOI: https://doi.org/10.3171/jns.1997.86.2.0233
11. Bogdanov EI, Mendelevich EG. Syrinx size and duration of symptoms predict the pace of progressive myelopathy: retrospective analysis of 103 unoperated cases with craniocervical junction malformations and syringomyelia. Clin Neurol Neurosurg. 2002 May;104(2):90-7. DOI: https://doi.org/10.1016/S0303-8467(01)00189-5
12. Goel A, Desai K. Surgery for syringomyelia: an analysis based on 163 surgical cases. Acta Neurochir (Wien). 2000;142(3):293-301; discussion 301-2. DOI: https://doi.org/10.1007/s007010050038
13. GARDNER WJ, ANGEL J. The mechanism of syringomyelia and its surgical correction. Clin Neurosurg. 1958;6:131-40. DOI: https://doi.org/10.1093/neurosurgery/6.CN_suppl_1.131
14. Wang X, Jiang C, Lu C, Ma L, Feng Y, Cui S, Li Q, Li K, Wang X, Jian F. Impairment of Connexin 43 may initiate cilia decline in syringomyelia. Exp Neurol. 2023 Jul;365:114430. DOI: https://doi.org/10.1016/j.expneurol.2023.114430
15. Zheng YC, Liu YT, Wei KC, Huang YC, Chen PY, Hsu YH, Lin CL. Outcome predictors and clinical presentation of syringomyelia. Asian J Surg. 2023 Feb;46(2):705-711. DOI: https://doi.org/10.1016/j.asjsur.2022.06.150
16. Halvorson KG, Kellogg RT, Keachie KN, Grant GA, Muh CR, Waldau B. Morphometric Analysis of Predictors of Cervical Syrinx Formation in the Setting of Chiari I Malformation. Pediatr Neurosurg. 2016;51(3):137-41. DOI: https://doi.org/10.1159/000442991
17. Milhorat TH, Capocelli AL, Anzil AP, Kotzen RM, Milhorat RH. Pathological basis of spinal cord cavitation in syringomyelia: analysis of 105 autopsy cases. J Neurosurg. 1995 May;82(5):802-12. DOI: https://doi.org/10.3171/jns.1995.82.5.0802
18. Batzdorf U, Khoo LT, McArthur DL. Observations on spine deformity and syringomyelia. Neurosurgery. 2007 Aug;61(2):370-7; discussion 377-8. DOI: https://doi.org/10.1227/01.NEU.0000279971.87437.1F
19. Weig SG, Buckthal PE, Choi SK, Zellem RT. Recurrent syncope as the presenting symptom of Arnold-Chiari malformation. Neurology. 1991 Oct;41(10):1673-4. DOI: https://doi.org/10.1212/WNL.41.10.1673
20. Gade SP, Harjpal P, Kovela RK. Novelty in Impact of Neurorehabilitation in a Classic Case of Syringomyelia. Cureus. 2022 Sep;14(9):e29126. DOI: https://doi.org/10.7759/cureus.29126
21. Van Der Veken J, Harding M, Hatami S, Agzarian M, Vrodos N. Syringomyelia intermittens: highlighting the complex pathophysiology of syringomyelia. Illustrative case. J Neurosurg Case Lessons. 2021 Sep 13;2(11):CASE21341. DOI: https://doi.org/10.3171/CASE21341
22. Oldfield EH. Pathogenesis of Chiari I - Pathophysiology of Syringomyelia: Implications for Therapy: A Summary of 3 Decades of Clinical Research. Neurosurgery. 2017 Sep 01;64(CN_suppl_1):66-77. DOI: https://doi.org/10.1093/neuros/nyx377
23. Clarke EC, Stoodley MA, Bilston LE. Changes in temporal flow characteristics of CSF in Chiari malformation Type I with and without syringomyelia: implications for theory of syrinx development. J Neurosurg. 2013 May;118(5):1135-40. DOI: https://doi.org/10.3171/2013.2.JNS12759
24. Williams B. On the pathogenesis of syringomyelia: a review. J R Soc Med. 1980 Nov;73(11):798-806. DOI: https://doi.org/10.1177/014107688007301109
25. Guan J, Yuan C, Zhang C, Ma L, Yao Q, Cheng L, Liu Z, Wang K, Duan W, Wang X, Wu H, Chen Z, Jian F. Intradural Pathology Causing Cerebrospinal Fluid Obstruction in Syringomyelia and Effectiveness of Foramen Magnum and Foramen of Magendie Dredging Treatment. World Neurosurg. 2020 Dec;144:e178-e188. DOI: https://doi.org/10.1016/j.wneu.2020.08.068
26. Arnautovic A, Splavski B, Boop FA, Arnautovic KI. Pediatric and adult Chiari malformation Type I surgical series 1965-2013: a review of demographics, operative treatment, and outcomes. J Neurosurg Pediatr. 2015 Feb;15(2):161-77. DOI: https://doi.org/10.3171/2014.10.PEDS14295
27. Oldfield EH, Muraszko K, Shawker TH, Patronas NJ. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg. 1994 Jan;80(1):3-15. DOI: https://doi.org/10.3171/jns.1994.80.1.0003
28. Brodbelt AR, Stoodley MA. Post-traumatic syringomyelia: a review. J Clin Neurosci. 2003 Jul;10(4):401-8. DOI: https://doi.org/10.1016/S0967-5868(02)00326-0
29. How Hong EA, Shalid A, Deepak S, Kounin G. Posterior Cranial Fossa Meningioma Causing Tonsillar Herniation and Giant Cervicothoracic Syringomyelia: Case Report and Review of Literature. Asian J Neurosurg. 2022 Sep;17(3):515-520. DOI: https://doi.org/10.1055/s-0042-1756634
30. Zuev AA, Kostenko GV. [Treatment of syringomyelia associated with Chiari 1 malformation]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3):102-106. DOI: https://doi.org/10.17116/jnevro201711731102-106
31. Williams B. Pathogenesis of syringomyelia. Lancet. 1972 Nov 04;2(7784):969-70. DOI: https://doi.org/10.1016/S0140-6736(72)92490-7
32. Roy AK, Slimack NP, Ganju A. Idiopathic syringomyelia: retrospective case series, comprehensive review, and update on management. Neurosurg Focus. 2011 Dec;31(6):E15. DOI: https://doi.org/10.3171/2011.9.FOCUS11198
33. Milhorat TH, Mu HT, LaMotte CC, Milhorat AT. Distribution of substance P in the spinal cord of patients with syringomyelia. J Neurosurg. 1996 Jun;84(6):992-8. DOI: https://doi.org/10.3171/jns.1996.84.6.0992
34. Milhorat TH, Miller JI, Johnson WD, Adler DE, Heger IM. Anatomical basis of syringomyelia occurring with hindbrain lesions. Neurosurgery. 1993 May;32(5):748-54; discussion 754. DOI: https://doi.org/10.1097/00006123-199305000-00008
35. Mariani C, Cislaghi MG, Barbieri S, Filizzolo F, Di Palma F, Farina E, D'Aliberti G, Scarlato G. The natural history and results of surgery in 50 cases of syringomyelia. J Neurol. 1991 Dec;238(8):433-8. DOI: https://doi.org/10.1007/BF00314649
36. Honey CM, Martin KW, Heran MKS. Syringomyelia Fluid Dynamics and Cord Motion Revealed by Serendipitous Null Point Artifacts during Cine MRI. AJNR Am J Neuroradiol. 2017 Sep;38(9):1845-1847. DOI: https://doi.org/10.3174/ajnr.A5328
37. Mampalam TJ, Andrews BT, Gelb D, Ferriero D, Pitts LH. Presentation of type I Chiari malformation after head trauma. Neurosurgery. 1988 Dec;23(6):760-2. DOI: https://doi.org/10.1227/00006123-198812000-00014
38. Roser F, Ebner FH, Sixt C, Hagen JM, Tatagiba MS. Defining the line between hydromyelia and syringomyelia. A differentiation is possible based on electrophysiological and magnetic resonance imaging studies. Acta Neurochir (Wien). 2010 Feb;152(2):213-9; discussion 219. DOI: https://doi.org/10.1007/s00701-009-0427-x
39. Yuan C, Guan J, Du Y, Fang Z, Wang X, Yao Q, Zhang C, Liu Z, Wang K, Duan W, Wang X, Wang Z, Wu H, Jian F. Neurological deterioration after posterior fossa decompression for adult syringomyelia: Proposal for a summarized treatment algorithm. Front Surg. 2022;9:968906. DOI: https://doi.org/10.3389/fsurg.2022.968906
40. Thi Phuong Dinh H, Tomohiko H, Madelar RT, Dinh Anh Hoang H, Yukihiro M. Giant-Cell Ependymoma of the Cervical Spinal Cord With Syringomyelia and Pathological Presentation: A Case Report and Review of the Literature. Cureus. 2022 Dec;14(12):e33174. DOI: https://doi.org/10.7759/cureus.33174
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
